Radnor Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Hold
1,257
0.04% 287
2026
Q1
$246K Hold
1,257
0.04% 285
2025
Q4
$218K Hold
1,257
0.03% 303
2025
Q3
$240K Hold
1,257
0.04% 302
2025
Q2
$226K Hold
1,257
0.04% 299
2025
Q1
$213K Buy
+1,257
New +$206K 0.04% 305
2024
Q4
Sell
-1,602
Closed -$249K 317
2024
Q3
$249K Buy
+1,602
New +$239K 0.04% 301
2023
Q1
Sell
-1,372
Closed -$205K 221
2022
Q4
$205K Buy
+1,372
New +$197K 0.05% 232
2022
Q2
Sell
-1,472
Closed -$201K 238
2022
Q1
$201K Hold
1,472
0.05% 233
2021
Q4
$255K Sell
1,472
-50
-3% -$7.61K 0.06% 221
2021
Q3
$221K Hold
1,522
0.13% 85
2021
Q2
$201K Buy
+1,522
New +$199K 0.07% 187
2020
Q3
Sell
-2,122
Closed -$242K 194
2020
Q2
$242K Buy
+2,122
New +$225K 0.09% 162
2020
Q1
Sell
-2,122
Closed -$227K 172
2019
Q4
$227K Hold
2,122
0.07% 172
2019
Q3
$227K Hold
2,122
0.07% 168
2019
Q2
$216K Buy
+2,122
New +$204K 0.07% 174
2018
Q1
Sell
-2,073
Closed -$204K 180
2017
Q4
$204K Buy
2,073
+233
+13% +$22.1K 0.07% 171
2017
Q3
$205K Hold
1,840
0.07% 169
2017
Q2
$205K Buy
+1,840
New +$195K 0.07% 169

Other funds holding DGX

Radnor Capital Management's DGX Position: Q2 2026 in Review

Radnor Capital Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,257 shares worth $266K. The position accounts for 0.04% of the portfolio, ranked #287.

Radnor Capital Management first reported a position in DGX in Q2 2017 and has held it in 19 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Radnor Capital Management held 1,257 shares of Quest Diagnostics worth $266K as of Q2 2026.
  • Radnor Capital Management left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.04% of Radnor Capital Management's portfolio in Q2 2026, its #287 holding.
  • Radnor Capital Management first reported a position in Quest Diagnostics in Q2 2017 and has held it in 19 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.